Diphenhydramine

Generic Name
Diphenhydramine
Brand Names
Acetadryl, Advil PM, Aleve PM, Allegra Cooling Relief Anti-itch, Banophen, Benadryl, Benadryl Itch Stopping, Benadryl-D Allergy and Sinus, Calagel, Damylin With Codeine, Dimetapp Nighttime Cold & Congestion, Diphen, Diphenhist, Diphenist, Excedrin PM Triple Action, Goody's PM, Legatrin PM, Motrin PM, Nytol, Nytol Quickgels, Percogesic Reformulated Jan 2011, Siladryl, Simply Sleep, Sleepinal, Sominex, Triaminic Night Time Cold & Cough, Tylenol PM, Unisom, Unisom Sleep, Vanamine, Wal-dryl, Wal-som (doxylamine), Zzzquil
Drug Type
Small Molecule
Chemical Formula
C17H21NO
CAS Number
58-73-1
Unique Ingredient Identifier
8GTS82S83M
Background

Diphenhydramine - perhaps known most commonly as its brand name formulation Benadryl - is a first-generation H1 receptor antihistamine that is used extensively for the treatment of seasonal allergies, insect bites and stings, and rashes . However, it also has antiemetic, antitussive, hypnotic, and antiparkinson properties . As histamine receptors exist both ...

Indication

Diphenhydramine is a first-generation histamine H1 receptor antagonist (H1 antihistamine) that is widely available as a non-prescription, over-the-counter (OTC) medication. As an OTC medication, diphenhydramine is typically formulated as tablets and creams indicated for use in treating sneezing, runny nose, itchy/watery eyes, itching of nose or throat, insom...

Associated Conditions
Allergic Reaction, Allergic Rhinitis (AR), Allergic cough, Allergy to Tree Pollen, Anaphylaxis, Angioedema, Common Cold, Conjunctival irritation, Cough, Cough Variant Asthma, Cough caused by Common Cold, Eye allergy, Fever, Insect Bites, Insect Stings, Insomnia, Irritative cough, Itching of the nose, Itching of the throat, Motion Sickness, Nasal Congestion, Oral Mucositis, Pain, Parkinsonian Syndromes, Productive cough, Pruritus, Rash, Rhinorrhoea, Sinus Congestion, Sinus headache, Skin Irritation, Sneezing, Sunburn, Symptoms of Acute Bronchitis Accompanied by Coughing, Upper respiratory tract hypersensitivity reaction, site unspecified, Urticaria, Cold or flu syndrome, Dermatographism, Dry cough, Watery itchy eyes
Associated Therapies
Airway secretion clearance therapy, Expectorant

Histamine Glutamate Antagonism in Stroke

First Posted Date
2014-05-20
Last Posted Date
2015-12-15
Lead Sponsor
University of Florida
Target Recruit Count
3
Registration Number
NCT02142712
Locations
🇺🇸

Shands Hospital at University of Florida, Gainesville, Florida, United States

Ketamine as a Rapidly-Acting Antidepressant in Depressed Emergency Department Patients

Phase 2
Completed
Conditions
Interventions
First Posted Date
2014-04-08
Last Posted Date
2018-09-14
Lead Sponsor
NYU Langone Health
Target Recruit Count
21
Registration Number
NCT02106325
Locations
🇺🇸

Bellevue Hospital Center, New York, New York, United States

🇺🇸

NYU Langone Medical Center/Tisch Hospital, New York, New York, United States

Haldol/Diphenhydramine Versus Metoclopramide/Diphenhydramine for Treatment of Acute Headache in the Emergency Department: A Randomized Controlled Trial

First Posted Date
2014-03-28
Last Posted Date
2014-03-28
Lead Sponsor
United States Naval Medical Center, Portsmouth
Target Recruit Count
68
Registration Number
NCT02098499
Locations
🇺🇸

Naval Medical Center Portsmouth, Portsmouth, Virginia, United States

A Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol Dependence

First Posted Date
2014-02-12
Last Posted Date
2022-11-08
Lead Sponsor
NYU Langone Health
Target Recruit Count
95
Registration Number
NCT02061293
Locations
🇺🇸

Clinical and Translational Science Institute, NYU Langone Medical Center, New York, New York, United States

🇺🇸

University of New Mexico Health Sciences Center, Albuquerque, New Mexico, United States

Psilocybin-facilitated Treatment for Cocaine Use

First Posted Date
2014-01-15
Last Posted Date
2024-10-24
Lead Sponsor
University of Alabama at Birmingham
Target Recruit Count
40
Registration Number
NCT02037126
Locations
🇺🇸

UAB Outpatient Clinical Research Unit, Birmingham, Alabama, United States

Pilot Phase III Clinical Trial of JDP-205 IV Injection for Treatment of Acute Urticaria

First Posted Date
2013-12-30
Last Posted Date
2024-02-09
Lead Sponsor
JDP Therapeutics, Inc.
Target Recruit Count
36
Registration Number
NCT02023164
Locations
🇨🇦

Del Carpio Independent Practice, Montréal, Quebec, Canada

🇨🇦

Glengarry Memorial Hospital, Independent Practice, Alexandria, Ontario, Canada

🇺🇸

OSU Hospitals, Department of Emergency Medicine, Columbus, Ohio, United States

and more 3 locations

Anti-histamines and Methacholine Challenges.

First Posted Date
2013-11-15
Last Posted Date
2015-04-08
Lead Sponsor
Don Cockcroft
Target Recruit Count
12
Registration Number
NCT01985789
Locations
🇨🇦

University of Saskatchewan, Saskatoon, Saskatchewan, Canada

© Copyright 2024. All Rights Reserved by MedPath